Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Feb;75(2):732–739. doi: 10.1172/JCI111754

Human B lymphoma cell line producing B cell growth factor.

J L Ambrus Jr, A S Fauci
PMCID: PMC423567  PMID: 2982918

Abstract

Namalva, a human B cell lymphoma line, produced a factor with a molecular weight of approximately 60,000 which enhanced the proliferation of normal activated human B lymphocytes. The factor also enhanced the proliferation of certain B cell lines. It can be distinguished physiologically and biochemically from other lymphokines known to enhance B cell proliferation, namely, interleukin (IL) 1, IL 2, and interferon. The production of B cell growth factor by B cell tumor lines may contribute to their ability to grow autonomously and may reflect an important component of the neoplastic potential of the cell. B cell growth factor produced by tumors may also affect normal cells in vivo.

Full text

PDF
732

Images in this article

736Image
on p.736

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J., Melchers F. T cell-dependent activation of resting B cells: requirement for both nonspecific unrestricted and antigen-specific Ia-restricted soluble factors. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2497–2501. doi: 10.1073/pnas.78.4.2497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blazar B. A., Sutton L. M., Strome M. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus. Cancer Res. 1983 Oct;43(10):4562–4568. [PubMed] [Google Scholar]
  3. Butler J. L., Ambrus J. L., Jr, Fauci A. S. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma. J Immunol. 1984 Jul;133(1):251–255. [PubMed] [Google Scholar]
  4. Butler J. L., Muraguchi A., Lane H. C., Fauci A. S. Development of a human T-T cell hybridoma secreting B cell growth factor. J Exp Med. 1983 Jan 1;157(1):60–68. doi: 10.1084/jem.157.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clark-Lewis I., Schrader J. W., Wu Y. Y., Harris A. W. A B lymphoma cell line produces growth factors for hemopoietic, lymphoid, and mast cells. Cell Immunol. 1982 May 1;69(1):196–200. doi: 10.1016/0008-8749(82)90064-8. [DOI] [PubMed] [Google Scholar]
  6. Dolyniuk M., Pritchett R., Kieff E. Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J Virol. 1976 Mar;17(3):935–949. doi: 10.1128/jvi.17.3.935-949.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dutton R. W. Separate signals for the initiation of proliferation and differentiation in the b cell response to antigen. Transplant Rev. 1975;23:66–77. doi: 10.1111/j.1600-065x.1975.tb00149.x. [DOI] [PubMed] [Google Scholar]
  8. Falkoff R. J., Muraguchi A., Hong J. X., Butler J. L., Dinarello C. A., Fauci A. S. The effects of interleukin 1 on human B cell activation and proliferation. J Immunol. 1983 Aug;131(2):801–805. [PubMed] [Google Scholar]
  9. Falkoff R. J., Zhu L. P., Fauci A. S. Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. J Immunol. 1982 Jul;129(1):97–102. [PubMed] [Google Scholar]
  10. Falkoff R. M., Peters M., Fauci A. S. T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations. J Immunol Methods. 1982;50(1):39–49. doi: 10.1016/0022-1759(82)90302-7. [DOI] [PubMed] [Google Scholar]
  11. Farrar J. J., Howard M., Fuller-Farrar J., Paul W. E. Biochemical and physicochemical characterization of mouse B cell growth factor: a lymphokine distinct from interleukin 2. J Immunol. 1983 Oct;131(4):1838–1842. [PubMed] [Google Scholar]
  12. Gordon J., Ley S. C., Melamed M. D., Aman P., Hughes-Jones N. C. Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus. J Exp Med. 1984 May 1;159(5):1554–1559. doi: 10.1084/jem.159.5.1554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gordon J., Ley S. C., Melamed M. D., English L. S., Hughes-Jones N. C. Immortalized B lymphocytes produce B-cell growth factor. Nature. 1984 Jul 12;310(5973):145–147. doi: 10.1038/310145a0. [DOI] [PubMed] [Google Scholar]
  14. Harada H., Shioiri-Nakano K., Mayumi M., Kawai T. Distinction of two subtypes of human leukocyte interferon (IFN-alpha) on B cell activation. B cell proliferation by two subtypes of IFN-alpha. J Immunol. 1983 Jul;131(1):238–243. [PubMed] [Google Scholar]
  15. Hooks J. J., Moutsopoulos H. M., Geis S. A., Stahl N. I., Decker J. L., Notkins A. L. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979 Jul 5;301(1):5–8. doi: 10.1056/NEJM197907053010102. [DOI] [PubMed] [Google Scholar]
  16. Howard M., Kessler S., Chused T., Paul W. E. Long-term culture of normal mouse B lymphocytes. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5788–5792. doi: 10.1073/pnas.78.9.5788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kaplan D. R., Henkel T. J., Braciale V., Braciale T. J. Mycoplasma infection of cell cultures: thymidine incorporation of culture supernatants as a screening test. J Immunol. 1984 Jan;132(1):9–11. [PubMed] [Google Scholar]
  18. Kappler J. W., Skidmore B., White J., Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med. 1981 May 1;153(5):1198–1214. doi: 10.1084/jem.153.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lachman L. B., Hacker M. P., Blyden G. T., Handschumacher R. E. Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines. Cell Immunol. 1977 Dec;34(2):416–419. doi: 10.1016/0008-8749(77)90263-5. [DOI] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Langone J. J. Radioiodination by use of the Bolton-Hunter and related reagents. Methods Enzymol. 1980;70(A):221–247. doi: 10.1016/s0076-6879(80)70052-6. [DOI] [PubMed] [Google Scholar]
  22. Maizel A. L., Morgan J. W., Mehta S. R., Kouttab N. M., Bator J. M., Sahasrabuddhe C. G. Long-term growth of human B cells and their use in a microassay for B-cell growth factor. Proc Natl Acad Sci U S A. 1983 Aug;80(16):5047–5051. doi: 10.1073/pnas.80.16.5047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Marrack P., Graham S. D., Jr, Kushnir E., Leibson H. J., Roehm N., Kappler J. W. Nonspecific factors in B cell responses. Immunol Rev. 1982;63:33–49. doi: 10.1111/j.1600-065x.1982.tb00410.x. [DOI] [PubMed] [Google Scholar]
  24. Meltzer M. S., Oppenheim J. J. Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells. J Immunol. 1977 Jan;118(1):77–82. [PubMed] [Google Scholar]
  25. Mizel S. B. Interleukin 1 and T cell activation. Immunol Rev. 1982;63:51–72. doi: 10.1111/j.1600-065x.1982.tb00411.x. [DOI] [PubMed] [Google Scholar]
  26. Muraguchi A., Butler J. L., Kehrl J. H., Fauci A. S. Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor. J Exp Med. 1983 Feb 1;157(2):530–546. doi: 10.1084/jem.157.2.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Okada M., Sakaguchi N., Yoshimura N., Hara H., Shimizu K., Yoshida N., Yoshizaki K., Kishimoto S., Yamamura Y., Kishimoto T. B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med. 1983 Feb 1;157(2):583–590. doi: 10.1084/jem.157.2.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pickering L. A., Kronenberg L. H., Stewart W. E., 2nd Spontaneous production of human interferon. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5938–5942. doi: 10.1073/pnas.77.10.5938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith K. A., Favata M. F., Oroszlan S. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol. 1983 Oct;131(4):1808–1815. [PubMed] [Google Scholar]
  30. Swain S. L., Howard M., Kappler J., Marrack P., Watson J., Booth R., Wetzel G. D., Dutton R. W. Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med. 1983 Sep 1;158(3):822–835. doi: 10.1084/jem.158.3.822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yoshizaki K., Nakagawa T., Fukunaga K., Tseng L. T., Yamamura Y., Kishimoto T. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. J Immunol. 1984 Jun;132(6):2948–2954. [PubMed] [Google Scholar]
  32. Yoshizaki K., Nakagawa T., Kaieda T., Muraguchi A., Yamamura Y., Kishimoto T. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol. 1982 Mar;128(3):1296–1301. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES